MELBOURNE, Aug 11 (Reuters) - Cochlear Ltd, the world's top maker of hearing implants, expects growth this year to be weighted to the second half as it awaits approvals for new products, the company said on Tuesday.
It said net profit rose 13 percent to A$130.5 million ($109.4 million) for the year to June, from A$115.2 million a year earlier, boosted by strong growth in sales of its hearing implants, and exactly in line with the company's forecast last month.
It raised its final dividend by 19 percent to A$0.95.
For the year ahead, analysts are expecting 13 percent profit growth, according to estimates tracker IBES. Cochlear, whose sales are mostly outside Australia, was hit by foreign exchange losses over the past year as the Australian dollar swung from near parity with the U.S. dollar at the start of the financial year, sank to $0.60 then climbed back to $0.80. (Reporting by Sonali Paul)
The one-time fiancée of cricketer Michael Clarke underwent a screen test for a job as an entertainment reporter at Bigpond TV. Unfortunately for ...
Continuing a trend in Queensland's residential property market, the number of sales of units and townhouses reduced markedly during the tail end ...
Two Australian school teachers from Warwick State High School have become the subject of controversy after posting raunchy photos of themselves i...
